Literature DB >> 12809708

Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus.

K Mizoguchi1, A Ishige, M Aburada, T Tabira.   

Abstract

Disruption of the glucocorticoid negative feedback system is observed in approximate one half of human depressives, and a similar condition is induced in animals by chronic stress. This disruption is thought to involve down-regulation of glucocorticoid receptors (GRs) in the feedback sites of the brain. However, the responsible site of the brain has not been well elucidated. Here we examined the effects of chronic stress induced by water immersion and restraint (2 h/day) for 4 weeks followed by recovery for 10 days on the GR levels in the prefrontal cortex (PFC), hippocampus, and hypothalamus of rats using a Western immunoblot technique. In the PFC, the cytosolic GR levels were decreased, but the nuclear GR levels were not changed. In the hippocampus, the levels of cytosolic and nuclear GRs were increased. However, there were no marked changes in the GR levels in the hypothalamus. The changes in the cytosolic GR levels were confirmed at the mRNA level by an in situ hybridization technique. We next examined the suppressive effects of dexamethasone (DEX) infusions into these regions on the circulating corticosterone levels. When DEX was infused into the PFC or hippocampus of the chronically stressed rats, the suppressive response to DEX was abolished, but the response was normal in the hypothalamus. In addition, when DEX was injected systemically to the chronically stressed rats, the suppressive response to DEX was significantly attenuated. These results suggest that the abnormal changes in GRs in the higher centers of the hypothalamo-pituitary-adrenal axis are involved in the chronic stress-induced attenuation of the feedback. Since dysfunction of the PFC or hippocampus is implicated in the pathogenesis of depression, the present findings would help to understand the mechanisms underlying the disrupted feedback system and its relation to brain dysfunction in depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809708     DOI: 10.1016/s0306-4522(03)00105-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  93 in total

1.  Expression of glucocorticoid receptor and early growth response gene 1 during postnatal development of two inbred strains of mice exposed to early life stress.

Authors:  Sylvia Navailles; Ross Zimnisky; Claudia Schmauss
Journal:  Dev Neurosci       Date:  2010-05-05       Impact factor: 2.984

Review 2.  The visible burrow system: A view from across the hall.

Authors:  James P Herman; Kellie L Tamashiro
Journal:  Physiol Behav       Date:  2017-01-12

3.  Modulation of central glucocorticoid receptors in short- and long-term experimental hyperthyroidism.

Authors:  Elena Nikolopoulou; Dimitrios Mytilinaios; Aldo E Calogero; Themis C Kamilaris; Theodore Troupis; George P Chrousos; Elizabeth O Johnson
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

4.  Inhibiting corticosterone synthesis during fear memory formation exacerbates cued fear extinction memory deficits within the single prolonged stress model.

Authors:  Samantha M Keller; William B Schreiber; Briana R Stanfield; Dayan Knox
Journal:  Behav Brain Res       Date:  2015-03-31       Impact factor: 3.332

Review 5.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

6.  Pathophysiology of depression: do we have any solid evidence of interest to clinicians?

Authors:  Gregor Hasler
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

7.  Stress-induced changes in corticosteroid receptor expression in primate hippocampus and prefrontal cortex.

Authors:  Paresh D Patel; Maor Katz; Adriaan M Karssen; David M Lyons
Journal:  Psychoneuroendocrinology       Date:  2008-01-28       Impact factor: 4.905

Review 8.  Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Authors:  Magnus Lekman; Silvia Paddock; Francis J McMahon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

9.  Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness.

Authors:  Duncan Sinclair; Shan Yuan Tsai; Heng Giap Woon; Cynthia Shannon Weickert
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

10.  Neuroendocrine Function After Hypothalamic Depletion of Glucocorticoid Receptors in Male and Female Mice.

Authors:  Matia B Solomon; Matthew Loftspring; Annette D de Kloet; Sriparna Ghosal; Ryan Jankord; Jonathan N Flak; Aynara C Wulsin; Eric G Krause; Rong Zhang; Taylor Rice; Jessica McKlveen; Brent Myers; Jeffrey G Tasker; James P Herman
Journal:  Endocrinology       Date:  2015-06-05       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.